Literature DB >> 23336055

Serotonin uptake is largely mediated by platelets versus lymphocytes in peripheral blood cells.

Brendan S Beikmann1, Ian D Tomlinson, Sandra J Rosenthal, Anne Milasincic Andrews.   

Abstract

The serotonin transporter (SERT), a primary target for many antidepressants, is expressed in the brain and also in peripheral blood cells. Although platelet SERT function is well accepted, lymphocyte SERT function has not been definitively characterized. Due to their small size, platelets often are found in peripheral blood mononuclear cell preparations aimed at isolating lymphocytes, monocytes, and macrophages. The presence of different cells makes it difficult to assign SERT expression and function to specific cell types. Here, we use flow cytometry and IDT307, a monoamine transporter substrate that fluoresces after uptake into cells, to investigate SERT function in lymphocyte and platelet populations independently, as well as simultaneously without prior isolation. We find that murine lymphocytes exhibit temperature-dependent IDT307 transport but uptake is independent of SERT. Lack of measurable SERT function in lymphocytes was corroborated by chronoamperometry using serotonin as a substrate. When we examined rhesus and human mixed blood cell populations, we found that platelets, and not lymphocytes, were primary contributors to SERT function. Overall, these findings indicate that lymphocyte SERT function is minimal. Moreover, flow cytometry, in conjunction with the fluorescent transporter substrate IDT307, can be widely applied to investigate SERT in platelets from populations of clinical significance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23336055      PMCID: PMC3547482          DOI: 10.1021/cn300146w

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  59 in total

1.  SLC6A4 expression and anti-proliferative responses to serotonin transporter ligands chlomipramine and fluoxetine in primary B-cell malignancies.

Authors:  Anita Chamba; Michelle J Holder; Ruth F Jarrett; Lesley Shield; Kai M Toellner; Mark T Drayson; Nicholas M Barnes; John Gordon
Journal:  Leuk Res       Date:  2010-04-02       Impact factor: 3.156

2.  Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters.

Authors:  J J Chen; Z Li; H Pan; D L Murphy; H Tamir; H Koepsell; M D Gershon
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

3.  Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase.

Authors:  Harish C Prasad; Chong-Bin Zhu; Jacob L McCauley; Devadoss J Samuvel; Sammanda Ramamoorthy; Richard C Shelton; William A Hewlett; James S Sutcliffe; Randy D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-29       Impact factor: 11.205

Review 4.  Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets.

Authors:  J O Marcusson; S B Ross
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Optofluidic fluorescent imaging cytometry on a cell phone.

Authors:  Hongying Zhu; Sam Mavandadi; Ahmet F Coskun; Oguzhan Yaglidere; Aydogan Ozcan
Journal:  Anal Chem       Date:  2011-08-02       Impact factor: 6.986

6.  The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics.

Authors:  Elizabeth J Meredith; Michelle J Holder; Anita Chamba; Anita Challa; Adrian Drake-Lee; Christopher M Bunce; Mark T Drayson; Geoffrey Pilkington; Randy D Blakely; Martin J S Dyer; Nicholas M Barnes; John Gordon
Journal:  FASEB J       Date:  2005-05-03       Impact factor: 5.191

7.  [3H]Paroxetine binding to human peripheral lymphocyte membranes of patients with major depression before and after treatment with fluoxetine.

Authors:  M Urbina; S Pineda; L Piñango; I Carreira; L Lima
Journal:  Int J Immunopharmacol       Date:  1999-10

8.  Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization.

Authors:  S Ramamoorthy; A L Bauman; K R Moore; H Han; T Yang-Feng; A S Chang; V Ganapathy; R D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

9.  Binding of paroxetine to the serotonin transporter in membranes from different cells, subcellular fractions and species.

Authors:  A Cupello; C Albano; E Gatta; S Scarrone; E Villa; G Zona
Journal:  Neurochem Res       Date:  2008-06-18       Impact factor: 3.996

10.  Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice.

Authors:  Nicole L Baganz; Rebecca E Horton; Alfredo S Calderon; W Anthony Owens; Jaclyn L Munn; Lora T Watts; Nina Koldzic-Zivanovic; Nathaniel A Jeske; Wouter Koek; Glenn M Toney; Lynette C Daws
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-24       Impact factor: 11.205

View more
  22 in total

1.  Toward Serotonin Fluorescent False Neurotransmitters: Development of Fluorescent Dual Serotonin and Vesicular Monoamine Transporter Substrates for Visualizing Serotonin Neurons.

Authors:  Adam Henke; Yekaterina Kovalyova; Matthew Dunn; Dominik Dreier; Niko G Gubernator; Iva Dincheva; Christopher Hwu; Peter Šebej; Mark S Ansorge; David Sulzer; Dalibor Sames
Journal:  ACS Chem Neurosci       Date:  2018-02-02       Impact factor: 4.418

2.  Perinatal vs genetic programming of serotonin states associated with anxiety.

Authors:  Stefanie C Altieri; Hongyan Yang; Hannah J O'Brien; Hannah M Redwine; Damla Senturk; Julie G Hensler; Anne M Andrews
Journal:  Neuropsychopharmacology       Date:  2014-12-19       Impact factor: 7.853

Review 3.  Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance.

Authors:  Natalie Terry; Kara Gross Margolis
Journal:  Handb Exp Pharmacol       Date:  2017

4.  Binding-induced fluorescence of serotonin transporter ligands: A spectroscopic and structural study of 4-(4-(dimethylamino)phenyl)-1-methylpyridinium (APP(+)) and APP(+) analogues.

Authors:  James N Wilson; Lucy Kate Ladefoged; W Michael Babinchak; Birgit Schiøtt
Journal:  ACS Chem Neurosci       Date:  2014-02-05       Impact factor: 4.418

5.  Potent and Selective Inhibition of Plasma Membrane Monoamine Transporter by HIV Protease Inhibitors.

Authors:  Haichuan Duan; Tao Hu; Robert S Foti; Yongmei Pan; Peter W Swaan; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2015-08-18       Impact factor: 3.922

Review 6.  Enteric Neuronal Regulation of Intestinal Inflammation.

Authors:  Kara Gross Margolis; Michael D Gershon
Journal:  Trends Neurosci       Date:  2016-07-20       Impact factor: 13.837

Review 7.  Thrombosis, platelets, microparticles and PAH: more than a clot.

Authors:  Katie L Lannan; Richard P Phipps; R James White
Journal:  Drug Discov Today       Date:  2014-04-18       Impact factor: 7.851

8.  Action potentials and amphetamine release antipsychotic drug from dopamine neuron synaptic VMAT vesicles.

Authors:  Kristal R Tucker; Ethan R Block; Edwin S Levitan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

9.  Loss of Serotonin Transporter Function Alters ADP-mediated Glycoprotein αIIbβ3 Activation through Dysregulation of the 5-HT2A Receptor.

Authors:  Kendra H Oliver; Matthew T Duvernay; Heidi E Hamm; Ana M D Carneiro
Journal:  J Biol Chem       Date:  2016-07-15       Impact factor: 5.157

10.  APP+, a fluorescent analogue of the neurotoxin MPP+, is a marker of catecholamine neurons in brain tissue, but not a fluorescent false neurotransmitter.

Authors:  Richard J Karpowicz; Matthew Dunn; David Sulzer; Dalibor Sames
Journal:  ACS Chem Neurosci       Date:  2013-05-06       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.